Current trends in essential thrombocythaemia.
Harrison
Claire N
CN
Department of Haematology, Guy's and St Thomas' Hospital NHS Trust, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK. claire.harrison@gstt.sthames.nhs.uk
D000208:Acute Disease; D001241:Aspirin / Q000627:therapeutic use; D001856:Bone Marrow Examination; D002999:Clone Cells; D004303:Dosage Compensation, Genetic; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications; D009857:Oncogenes; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D055728:Primary Myelofibrosis / Q000150:complications; D011379:Prognosis; D012306:Risk; D013921:Thrombocytopenia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D013926:Thrombopoietin / Q000235:genetics
D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D013926:Thrombopoietin; D001241:Aspirin